Projects

A prospective randomised, double blind, two arm, parallel, placebo controlled, comparative multicentre clinical study to evaluate the safety and efficacy of Dynapar PS compared to placebo topical solution for treatment of osteoarthritis of knee

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2015 - 2015

Project Lead

Dr Joe Joseph Cherian

Authors

Dr. Joe Joseph Cherian

Project Status

completed

Project Type

Phase III